CLINICAL_TRIALS
trial_result
· 2011-07-13
Clinical Trial Update: Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE) [Phase 3]
Summary
Phase 3 ASPIRE trial evaluating aliskiren for safety and efficacy in patients after myocardial infarction; results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2011-07-13